Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Pharmacological profile of KF-19418 suggests potential in human alopecia

July 5, 2001

Small-molecule LFA-1 antagonist enters phase I studies

July 3, 2001

Fujisawa's Protopic approved in Canada

June 28, 2001

Health Canada approves Levulan Kerastick

June 27, 2001

Cellegy files NDA for Anogesic; completes enrollment in second phase III trial

June 27, 2001

Pivotal data reported for Xanelim in psoriasis

June 27, 2001

Chemokine antagonists claimed for wide series of conditions in recent patent

June 26, 2001

International Psoriasis Symposium selected by MedImmune to present phase I results for MEDI-507

June 26, 2001

BioMarin files application to conduct human trials with topical Vibriolysin

June 26, 2001

Phase II clinical trial of ISIS-104838 commences in patients with psoriasis

June 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...